The effects of phosphoramidon on the regional haemodynamic responses to human proendothelin [1–38] in conscious rats

No abstract is available for this paper.

• Publication year

  1991

• Venue

  British Journal of Pharmacology

• Publication date

  1991-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1476-5381.1991.tb12368.xPMID 1912989PMCID PMC1908215
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Responses to endothelin-1, human proendothelin (1-38) and porcine proendothelin (1-39) in the rat on intravenous administration and in the blood perfused mesentery.

  1991cited by this paper
• Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro.

  1991cited by this paper
• Intravascular big endothelin increases circulating levels of endothelin-1 and prostanoids in the rabbit.

  1990cited by this paper
• Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big endothelin-1.

  1990cited by this paper
• Effects of indomethacin on the regional haemodynamic responses to low doses of endothelins and sarafotoxin

  1990cited by this paper
• Inhibition of biological actions of big endothelin-1 by phosphoramidon.

  1990cited by this paper
• In vivo metabolism of brain natriuretic peptide in the rat involves endopeptidase 24.11 and angiotensin converting enzyme.

  1990cited by this paper
• Degradation and clearance of atrial natriuretic factors (ANF).

  1990cited by this paper
• Vasodilation induced by endothelin: role of EDRF and prostanoids in rat hindquarters.

  1990cited by this paper
• Regional haemodynamic effects of endothelin‐1 and endothelin‐3 in conscious Long Evans and Brattleboro rats

  1990cited by this paper
• Regional and cardiac haemodynamic effects of NG‐nitro‐l‐arginine methyl ester in conscious, Long Evans rats

  1990cited by this paper
• Neutral metalloendopeptidase inhibition: a novel means of circulatory modulation.

  1990cited by this paper
• Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: possible physiological significance.

  1990cited by this paper
• Opposite effects of endothelin-1 and Big-endothelin-(1-39) on renal function in rats.

  1990cited by this paper
• Regional Hemodynamic Effects of Endothelin‐1 in Conscious, Unrestrained, Wistar Rats

  1989cited by this paper
• NG-monomethyl-L-arginine does not inhibit the hindquarters vasodilator action of endothelin-1 in conscious rats.

  1989cited by this paper
• Regional hemodynamic effects of calcitonin gene-related peptide.

  1989cited by this paper
• Putative precursors of endothelin have less vasoconstrictor activity in vitro but a potent pressor effect in vivo

  1989cited by this paper
• Regional haemodynamic effects of depressor neuropeptides in conscious, unrestrained, Long Evans and Brattleboro rats

  1988cited by this paper
• A novel potent vasoconstrictor peptide produced by vascular endothelial cells

  1988cited by this paper
• Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo.

  1987cited by this paper
• Friedman and Quade tests: BASIC computer program to perform nonparametric two-way analysis of variance and multiple comparisons on ranks of several related samples.

  1987cited by this paper
• Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat.

  1981cited by this paper

• Effect of endothelin‐1 on the blood pressure response to acute hypoxia and hyperoxia in healthy young men

  2024cites this paper
• Endothelin and the heart in health and diseases

  2019cites this paper
• Positron emission tomography of [18F]‐big endothelin‐1 reveals renal excretion but tissue‐specific conversion to [18F]‐endothelin‐1 in lung and liver

  2010influential citation
• Efecto de los isoprostanos en la reactividad vascular pulmonar y sistémica durante el período neonatal.

  2005cites this paper
• Plasma endothelin-1 immunoreactivity in normal dogs and dogs with acquired heart disease.

  2004cites this paper
• The endothelin receptor antagonist ameliorates the hypertensive phenotypes of transgenic hypertensive mice with renin-angiotensin genes and discloses roles of organ specific activation of endothelin system in transgenic mice.

  2004cites this paper
• Role of endothelin in cardiovascular disease

  2002cites this paper
• Phosphoramidon treatment improves the consequences of chagasic heart disease in mice.

  2002cites this paper
• Cardioprotective effects of phosphoramidon on myocardial structure and function in murine Chagas' disease.

  2002cites this paper
• Role of endothelin in cardiovascular disease

  2002cites this paper
• Endothelin system: the double-edged sword in health and disease.

  2001cites this paper
• Roles of vasopressin and endothelin in deoxycorticosterone acetate-salt hypertensive rats

  2000cites this paper
• Pathophysiology of endothelin in the cardiovascular system.

  1999cites this paper
• The role of endothelin in hypertension

  1998cites this paper
• Endothelin as a regulator of cardiovascular function in health and disease

  1998cites this paper
• The Renal and Systemic Hemodynamic Actions of Endothelin

  1998cites this paper
• Biosynthesis, distribution and metabolism of endothelins in the pulmonary system.

  1998cites this paper
• Evidence for functional endothelin-converting enzyme activity in isolated rat basilar artery: effect of inhibitors.

  1998cites this paper
• Physiological role of the endothelin system in human cardiovascular and renal haemodynamics.

  1997cites this paper
• Endothelin and nitric oxide in hepatorenal syndrome: a balance reset.

  1997cites this paper
• Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats

  1997cites this paper
• Phosphoramidon, an endothelin converting enzyme inhibitor attenuates local gastric ischemia-reperfusion injury in rats.

  1997cites this paper
• Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans.

  1996cites this paper
• Endothelin blockade augments pulmonary vasodilation in the ovine fetus.

  1996cites this paper
• Molecular pharmacology and pathophysiological significance of endothelin.

  1996cites this paper
• The conformation of human big endothelin-1 favours endopeptidase hydrolysis of the TRP21-VAL22 bond.

  1996cites this paper
• The endothelin system and its potential as a therapeutic target in cardiovascular disease.

  1996cites this paper
• Radioimmunoassay evidence that the pressor effect of big endothelin-1 is due to local conversion to endothelin-1.

  1995cites this paper
• Phosphoramidon inhibition of the in vivo conversion of big endothelin‐1 to endothelin‐1 in the human forearm

  1995cites this paper
• Role of endothelin-converting enzyme in the systemic hemodynamics and regional circulatory effects of proendothelin-1 (1-38) and diaspirin cross-linked hemoglobin in rats.

  1995cites this paper
• Measurement of C‐Terminal Fragment of Big Endothelin‐1: A Novel Method for Assessing the Generation of Endothelin‐1 in Humans

  1995cites this paper
• Radioimmunoassay evidence that the pressor effect of big endothelindash1 is due to local conversion to endothelindash1

  1995cites this paper
• Phosphoramidon inhibition oftheinvivoconversion ofbig endothelin-1 toendothelin-1 inthehumanforearm

  1995cites this paper
• A role for endothelin in bicuculline‐induced neurogenic pulmonary oedema in rats

  1995cites this paper
• Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA‐ETB antagonist

  1994cites this paper
• Effects of an ET1‐receptor antagonist, FR139317, on regional haemodynamic responses to endothelin‐1 and [Ala11,15]Ac‐endothelin‐1 (6–21) in conscious rats

  1994cites this paper
• Effects of bosentan (Ro 47–0203), an ETA‐, ETB‐receptor antagonist, on regional haemodynamic responses to endothelins in conscious rats

  1994cites this paper
• Effects of phosphoramidon and pepstatin A on the secretion of endothelin-1 and big endothelin-1 by human umbilical vein endothelial cells: measurement by two-site enzyme-linked immunosorbent assays.

  1994cites this paper
• Structure activity relationship of phosphoramidon derivatives for in vivo endothelin‐converting‐enzyme inhibition

  1994cites this paper
• Systemic and pulmonary hemodynamic effects of big endothelin-1 and phosphoramidon in the ovine fetus.

  1994cites this paper
• Identification and characterization of endothelin converting activity from EAHY 926 cells: evidence for the physiologically relevant human enzyme.

  1994cites this paper
• Intrarenal conversion of big endothelin-1 to endothelin-1 in the rat.

  1994cites this paper
• The control of endothelin-1 secretion.

  1994cites this paper
• Regional haemodynamic responses to intravenous and intraarterial endothelin‐1 and big endothelin‐1 in conscious rats

  1993cites this paper
• Chapter 3 – Endothelial-Derived Relaxing Factors: Focus on Nitric Oxide

  1993cites this paper
• Endothelins: circulating plasma levels and presence in other biologic fluids.

  1993cites this paper
• In-vivo effects of endothelin-1 and ETA receptor blockade on arterial, venous and capillary functions in skeletal muscle.

  1993cites this paper
• Downregulation of endothelin receptors by autocrine production of endothelin-1.

  1993cites this paper
• Big endothelin-1 and big endothelin-3 are constrictor agents in the microvasculature: evidence for the local phosphoramidon-sensitive conversion of big endothelin-1.

  1993cites this paper
• Phosphoramidon inhibits the conversion of big ET-1 into ET-1 in the pithed rat and in isolated perfused rat kidneys.

  1993cites this paper
• In vivo pharmacology of Ro 46-2005, the first synthetic nonpeptide endothelin receptor antagonist: implications for endothelin physiology.

  1993cites this paper
• Ontogeny of Big endothelin-1 effects in newborn piglet pulmonary vasculature.

  1993cites this paper
• Effects of the neutral endopeptidase inhibitor, SQ 28,603, on regional haemodynamic responses to atrial natriuretic peptide or proendothelin‐1 [1–38] in conscious rats

  1992cites this paper
• Coeliac haemodynamic effects of endothelin‐1, endothelin‐3, proendothelin‐1 [1–38] and proendothelin‐3 [1–41] in conscious rats

  1992cites this paper
• Inhibition by phosphoramidon of the regional haemodynamic effects of proendothelin−2 and −3 in conscious rats

  1992cites this paper
• Endothelin‐converting enzymes

  1992cites this paper